Evidence map›Paper›PMID 26374826›Full record

ArticleCirculation. Cardiovascular genetics2015

Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway.

Olga V Fedorova, Valentina I Zernetkina, Victoria Y Shilova, Yulia N Grigorova, Ondrej Juhasz, Wen Wei, Courtney A Marshall, Edward G Lakatta, Alexei Y Bagrov

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Cardiovascular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Sensational site: the sodium pump ouabain-binding site and its ligands.American journal of physiology. Cell physiology · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. The NaFrontiers in endocrinology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. NaInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Olga V FedorovaFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD. fedorovo@mail.nih.gov BagrovA@mail.nih.gov.
Valentina I ZernetkinaFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Victoria Y ShilovaFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Yulia N GrigorovaFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Ondrej JuhaszFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Wen WeiFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Courtney A MarshallFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Edward G LakattaFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Alexei Y BagrovFrom the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD. fedorovo@mail.nih.gov BagrovA@mail.nih.gov.
Institute on Aging · USNational Institute on Aging · US

Funding

Sodium pump ligands in blood pressure regulation and profibrotic signaling in hypertension, chronic kidney disease and aging in males and femalesZIAAG000609 · NIA · NATIONAL INSTITUTE ON AGING · PI FEDOROVA, OLGA V · 2009 to 2025
$17.3M
Marinobufagenin as a therapeutic targetZIAAG000869 · NIA · NATIONAL INSTITUTE ON AGING · PI LAKATTA, EDWARD · 2009 to 2025
$14.8M
Aging and interaction of natriuretic factors on renal and vascular sodium pumpZIAAG000868 · NIA · NATIONAL INSTITUTE ON AGING · PI BAGROV, ALEXEI · 2009 to 2015
$2.7M
SODIUM PUMP INHIBITORS IN CARDIOVASCULAR CONTROLZ01AG000609 · NIA · NATIONAL INSTITUTE ON AGING · PI BAGROV, ALEXEI Y · 1993 to 2008
$1.2M
Aging and interaction of natriuretic factors on renal and vascular sodium pumpZ01AG000868 · NIA · NATIONAL INSTITUTE ON AGING · PI BAGROV, ALEXEI · 2008 to 2008
$389k
Intramural NIH HHS Z01 AG000609Intramural NIH HHS Z01 AG000868
6 · The paper itself

Abstract

backgroundThe bioactive steroid, marinobufagenin, is an endogenous Na/K-ATPase bufadienolide inhibitor that is synthesized by adrenocortical and placental cells. Marinobufagenin binding to Na/K-ATPase initiates profibrotic cell signaling, and heightened marinobufagenin levels are implicated in the pathogenesis of hypertension, preeclampsia, and chronic kidney disease. Steroids are derived from cholesterol through the traditional steroidogenesis pathway initiated by enzyme CYP11A1, and via the acidic bile acid pathway, which is controlled by enzyme CYP27A1. The mechanism of marinobufagenin biosynthesis in mammals, however, remains unknown. METHODS AND

resultsHere, we show that post-transcriptional silencing of the CYP27A1 gene in human trophoblast and rat adrenocortical cells reduced the expression of CYP27A1 mRNA by 70%, reduced total bile acids 2-fold, and marinobufagenin levels by 67% when compared with nontreated cells or cells transfected with nontargeting siRNA. In contrast, silencing of the CYP11A1 gene did not affect marinobufagenin production in either cell culture, but suppressed production of progesterone 2-fold in human trophoblast cells and of corticosterone by 90% in rat adrenocortical cells when compared with cells transfected with nontargeting siRNA. In vivo, in a high-salt administration experiment, male and female Dahl salt-sensitive rats became hypertensive after 4 weeks on a high-NaCl diet, their plasma marinobufagenin levels doubled, and adrenocortical CYP27A1 mRNA and protein increased 1.6-fold and 2.0-fold.

conclusionsTherefore, the endogenous steroidal Na/K-ATPase inhibitor, marinobufagenin, is synthesized in mammalian placenta and adrenal cortex from cholesterol through the novel acidic bile acid pathway. These findings will help to understand the role of marinobufagenin in highly prevalent human cardiovascular diseases.

Indexed as

Adrenal CortexAnimalsBile Acids and SaltsBufanolidesCardiovascular DiseasesCell Line, TumorCells, CulturedCholestanetriol 26-MonooxygenaseCholesterol Side-Chain Cleavage EnzymeFemaleHumansMalePregnancyRatsRats, Inbred DahlRNA InterferenceBile Acids and SaltsBufanolidesCholestanetriol 26-MonooxygenaseCholesterol Side-Chain Cleavage EnzymeCYP27A1 protein, humanCyp27a1 protein, ratmarinobufageninSodium-Potassium-Exchanging ATPasebiosynthesisCYP27A1 proteinDahl Salt-Sensitive Ratsgene silencinghypertensionNa-K ATPase inhibitornatriuretic hormonessteroids

Identifiers

PMID26374826
PMCPMC4618091
OpenAlexW2175085770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.